Literature DB >> 9357621

Willingness-to-pay utility assessment: feasibility of use in normative patient decision support systems.

C R Flowers1, A M Garber, M R Bergen, L A Lenert.   

Abstract

The authors developed an automated patient interviewing tool to elicit individuals' willingness-to-pay (WTP) utilities under conditions of uncertainty and examined the reliability of this method and its potential usefulness in clinical decision support. We tested this method in 52 healthy volunteers using a computer-based interview that trained subjects in standard gamble (SG) and WTP methods, and elicited preferences for moderate Gaucher disease using WTP and SG. We assessed the validity of the WTP method by calculating the cost-effectiveness threshold implied by subjects' WTP and SG utilities; we also assessed subjects' understanding and comfort with using WTP for decision making by a questionnaire. The WTP method had good test-retest reliability (r = 0.796), and produced a cost-effectiveness ratio and ratings for understanding and clarity that support its validity. Moreover, many subjects felt that WTP was a reasonable (83%) method for therapeutic decision making and expressed comfort (62%) in using the method for their own health care decisions. These results suggest that a probabilistic method for WTP utility assessment is potentially useful for acquiring patient preferences for use in normative decision support systems.

Entities:  

Mesh:

Year:  1997        PMID: 9357621      PMCID: PMC2233361     

Source DB:  PubMed          Journal:  Proc AMIA Annu Fall Symp        ISSN: 1091-8280


  14 in total

1.  Representation of preferences in decision-support systems.

Authors:  B R Farr; R D Shachter
Journal:  Comput Biomed Res       Date:  1992-08

Review 2.  Assessing patients' utilities. Can the ends justify the means?

Authors:  A G Mulley
Journal:  Med Care       Date:  1989-03       Impact factor: 2.983

3.  Utilities and quality-adjusted life years.

Authors:  G W Torrance; D Feeny
Journal:  Int J Technol Assess Health Care       Date:  1989       Impact factor: 2.188

4.  Toward normative expert systems: Part I. The Pathfinder project.

Authors:  D E Heckerman; E J Horvitz; B N Nathwani
Journal:  Methods Inf Med       Date:  1992-06       Impact factor: 2.176

5.  U-titer: a utility assessment tool.

Authors:  W Sumner; R Nease; B Littenberg
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1991

6.  Willingness-to-pay as a measure of benefits. Relevant questions in the context of public decisionmaking about health care programs.

Authors:  A Gafni
Journal:  Med Care       Date:  1991-12       Impact factor: 2.983

7.  Methodology for measuring health-state preferences--I: Measurement strategies.

Authors:  D G Froberg; R L Kane
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

8.  Willingness to pay: a valid and reliable measure of health state preference?

Authors:  B O'Brien; J L Viramontes
Journal:  Med Decis Making       Date:  1994 Jul-Sep       Impact factor: 2.583

9.  Clinical decision analysis by personal computer.

Authors:  S G Pauker; J P Kassirer
Journal:  Arch Intern Med       Date:  1981-12

10.  Automated computer interviews to elicit utilities: potential applications in the treatment of deep venous thrombosis.

Authors:  L A Lenert; R M Soetikno
Journal:  J Am Med Inform Assoc       Date:  1997 Jan-Feb       Impact factor: 4.497

View more
  3 in total

1.  Vision and quality-of-life.

Authors:  G C Brown
Journal:  Trans Am Ophthalmol Soc       Date:  1999

Review 2.  "I can't afford that!": dilemmas in the care of the uninsured and underinsured.

Authors:  S Weiner
Journal:  J Gen Intern Med       Date:  2001-06       Impact factor: 5.128

3.  Oral sildenafil (Viagra) in male erectile dysfunction: use, efficacy and safety profile in an unselected cohort presenting to a British district general hospital.

Authors:  Krishnamurthy Sairam; Elena Kulinskaya; Damian Hanbury; Gregory Boustead; Thomas McNicholas
Journal:  BMC Urol       Date:  2002-04-18       Impact factor: 2.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.